Orelabrutinib Followed by Response-adapted Ultra-low Dose 4Gy Radiation as First-line Treatment of MALT Lymphoma
Fudan University
Fudan University
Memorial Sloan Kettering Cancer Center
Stanford University
Stanford University
City of Hope Medical Center
Stanford University
Trans Tasman Radiation Oncology Group